Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fojo, Tito
NCT05422911: Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.	Not yet recruiting	2	200	US	Abiraterone acetate, Apalutamide, Enzalutamide	James J. Peters Veterans Affairs Medical Center	Metastatic Cancer, Neoplasm, Prostate	06/25	06/26